XTL Biopharmaceuticals Ltd.

Regulatory Filings • Mar 31, 2016

_________ false

C003��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: NASDAQ CM1996381HaCharoshet st 5 , Ra'anana 43656 , Israel ,Tel: 09-9557080 , Fax: 09-9519708E.mail address: ir@xtlbio.comReported via MAGNA: 31/03/2016              Time of broadcast: 16:19 15:43:19

Company site:		www.xtlbio.com

Reference: 2016-02-021918

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Annual General Meeting Results.

20160331_XTLB_6K_AGM_Results_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 03/03/2016
- - -
Name of the Signatory: : Kntor Ronen , Position of Signatory in the reporting corporation: Attorney/Legal Counsel , Name of Employer Company: .
abba hillel 12 ramat gan 5250606 Telephone: 972-3613337 , Facsimile: 03-6133372 , E-mail: rkantor@dtkgc.com 1